関連する実験動画
Updated: Feb 14, 2026

11:22
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
Published on: December 1, 2017
12.9K
GalNAc-siRNA結合体の精巧な設計と液相組成:PCSK9ターゲティングにおける比較効率の検証
Nikolai A Dmitriev1, Petr V Chernov1, Ivan S Gongadze1
1National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia.
Molecules (Basel, Switzerland)
|February 13, 2026
まとめ
研究者らは,PCSK9遺伝子を標的とするGalNAc-siRNA結合体の新しい合成方法を開発した. この進歩により,治療用オリゴヌクレオチドの投与が改善され,潜在的な医薬品用用の製造コストが削減されます.
科学分野:
- バイオメディシンは生物医学です.
- 分子生物学は分子生物学である.
- ドラッグ開発 ドラッグ開発
背景:
- siRNAのような治療用オリゴヌクレオチドは,生物医学で成長している分野です.
- 課題には,ターゲットを絞った配送と高い生産コストが含まれます.
- GalNAc結合体は,ASGPR経由で肝細胞に標的を絞った投与を提供しますが,合成方法は限られています.
研究 の 目的:
- リガンド-オリゴヌクレオチド結合体の新しい合成方法を開発する.
- 心血管疾患のリスクを減らすためにPCSK9遺伝子を標的としたGalNAc-L96-siRNA結合体を作成する.
- コスト効率とスケーラビリティのために合成を最適化します.
主な方法:
- GalNAc L-96リガンドとのsiRNA結合のライブラリを設計・合成した.
- 安定性,特異性,および有効性に基づいて最適なsiRNA配列を選択するために,in silicoアルゴリズムを使用しました.
- 結合効果を確認するために,インビトロ肝細胞細胞モデルを確立しました.
主要な成果:
- 製造コストを大幅に削減する最適化された合成プロセスを開発しました.
- PCSK9.9を標的にする高効率のGalNAc-siRNA結合体が特定されました.
- in silico-optimized siRNAコンジュガートの優れた阻害効果が商用アナログ in vitroと比較して実証されています.
結論:
- この新しい合成方法は,GalNAc-siRNA結合体の費用対効果が高く,スケーラブルな生産を可能にします.
- 最適化されたsiRNA配列は,治療性オリゴヌクレオチドの抑制効果を高めます.
- この研究は,標的型オリゴヌクレオチド治療の医薬品応用を促進します.
関連する概念動画
siRNA - Small Interfering RNAs
18.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
Phase II Conjugation Reactions: Overview
910
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
910
Phase II Reactions: Miscellaneous Conjugation Reactions
377
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
377
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
1.0K
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
1.0K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
978
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
978
Reliability and Validity
14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K

